ReviewAnnals of medicine and surgery (2012)2024
Pembrolizumab in combination with trastuzumab for treatment of HER2-positive advanced gastric or gastro-esophageal junction cancer.
Zaheer Qureshi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.